Daily non-political popular news in brief.

Drug industry increasingly influences breast cancer research

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Read more »

Keywords: drug, industry, increasingly, influences, breast, cancer, research, influence

« Previous | Next »

Similar news on "Drug industry increasingly influences breast cancer research":

1. Other highlights in the Nov. 13 JNCI
   11-13-2007 · EurekAlert!
   Other highlights in the Nov. 13 JNCI include a simple model to predict breast cancer risk, the link between smoking and rectal cancer, research into how a cancer drug causes heart damage, a gene that may inhibit lung cancer, BRCA1's influence on drug response, and the difficulties assigning patients to cancer subtypes.
   Similar news · Read more »
   
2. Breast cancer drug receives FDA approval
   11-17-2006 · EurekAlert!
   Doctor instrumental in research says this is dramatic leap forward in breast cancer treatment.
   Similar news · Read more »
   
3. Ireland Cancer Center researcher finds standard treatment for breast cancer not followed
   12-21-2007 · EurekAlert!
   Research out of the Ireland Cancer Center of University Hospitals Case Medical Center, in collaboration with six integrated health plans that are part of the Cancer Research Network, found that the majority of older women with early stage breast cancer fail to adhere to the standard of treatment -- five years of daily oral use of the chemo-prevention drug Tamoxifen.
   Similar news · Read more »
   
4. Weekly dose of osteoporosis drug prevents bone loss after breast cancer treatment
   09-18-2007 · EurekAlert!
   Breast cancer survivors who took a weekly dose of risedronate, sold as Actonel, lost significantly less bone than those who did not take the drug, according to a two-year study from the University of Pittsburgh School of Medicine presented this week at the 29th annual meeting of the American Society for Bone and Mineral Research.Researchers evaluated 87 women enrolled in the Prevention of Osteoporosis in Postmenopausal Women with Breast Cancer Following Chemotherapy study.
   Similar news · Read more »
   
5. Restoring tamoxifen sensitivity in resistant breast cancer cells
   12-20-2006 · EurekAlert!
   The widely used breast cancer drug tamoxifen (Nolvadex), which can become less effective over time, might retain its full strength indefinitely if used along with a second drug, according to new research in mice conducted by investigators from the National Cancer Institute, part of the National Institutes of Health, and their partners.
   Similar news · Read more »
   
6. Breast cancer survival rates improved by novel drug sequence, say researchers
   02-12-2007 · EurekAlert!
   Changing the way women are treated for breast cancer could improve their overall chance of survival, according to research published today in the Lancet. The new paper shows that switching to a drug called exemestane, two to three years after commencing standard therapy with the drug tamoxifen, can cut the risk of death for certain women by a further 17 percent compared with using tamoxifen alone.
   Similar news · Read more »
   
7. Friends' school achievement influences high school girls' interest in math
   02-07-2008 · EurekAlert!
   Though girls now take as many math courses as boys in high school, new research finds that one's friends have a stronger influence on girls' decisions to take higher level math classes than on boys. Both girls and boys who had close friends who made good grades took more higher-level math than other teens. However the findings suggest that we should examine the reasons why boys and girls take different paths to the same outcome.
   Similar news · Read more »
   
8. Study links breast cancer risk to epigenetic changes related to race, smoking and birth size
   04-15-2007 · EurekAlert!
   Women can encounter environmental factors that increase their risk of breast cancer at various periods of their physical development, beginning before birth and extending until menopause. These non-inherited, or epigenetic, changes in DNA can correlate with risk factors for breast cancer, according to research being presented at the 2007 Annual Meeting of the American Association for Cancer Research.
   Similar news · Read more »
   
9. Molecular signature may identify cisplatin-sensitive breast tumors
   04-19-2007 · EurekAlert!
   Researchers at the Massachusetts General Hospital Cancer Center have identified a subgroup of hard-to-treat breast cancers that may be sensitive to the drug cisplatin, rarely used in the treatment of breast tumors. They also have discovered the molecular basis of this sensitivity, which may help identify patients most likely to benefit from cisplatin treatment.
   Similar news · Read more »
   
10. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
    08-08-2007 · EurekAlert!
    Today Almac Diagnostics announced a major study analyzing ductal carcinoma in situ tissue samples using its novel Breast Cancer DSA microarray. DSA research tools focus on the transcriptome of an individual disease, in this case breast cancer, and contain significant additional data relevant to the disease of interest that is not available on other generic microarrays.
    Similar news · Read more »